SG10201801156RA - Beta-casein a2 and blood glucose levels - Google Patents

Beta-casein a2 and blood glucose levels

Info

Publication number: SG10201801156RA
Authority: SG; Singapore
Prior art keywords: casein; beta; blood glucose; glucose levels; levels
Prior art date: 2013-08-23

Application number

SG10201801156RA

Inventor

Andrew John Clarke

Original Assignee

A2 Milk Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-08-23

Filing date

2014-08-22

Publication date

2018-03-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52483940&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201801156R(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-08-22 Application filed by A2 Milk Co Ltd filed Critical A2 Milk Co Ltd

2018-03-28 Publication of SG10201801156RA publication Critical patent/SG10201801156RA/en

Links

102000011632 Caseins Human genes 0.000 title 1
108010076119 Caseins Proteins 0.000 title 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title 1
239000008280 blood Substances 0.000 title 1
210000004369 blood Anatomy 0.000 title 1
239000008103 glucose Substances 0.000 title 1
235000021247 β-casein Nutrition 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
- A23J1/202—Casein or caseinates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
- A23V2250/542—Animal Protein
- A23V2250/5424—Dairy protein
- A23V2250/54246—Casein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Polymers & Plastics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Food Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Mycology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Marine Sciences & Fisheries (AREA)
Hematology (AREA)
Obesity (AREA)
Animal Husbandry (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pediatric Medicine (AREA)
Virology (AREA)
Cell Biology (AREA)
Developmental Biology & Embryology (AREA)
Biotechnology (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Child & Adolescent Psychology (AREA)
Heart & Thoracic Surgery (AREA)

SG10201801156RA 2013-08-23 2014-08-22 Beta-casein a2 and blood glucose levels SG10201801156RA (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201361869213P	2013-08-23	2013-08-23

Publications (1)

Publication Number	Publication Date
SG10201801156RA true SG10201801156RA (en)	2018-03-28

Family

ID=52483940

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SG11201600670VA SG11201600670VA (en)	2013-08-23	2014-08-22	Beta-casein a2 and blood glucose levels
SG10201801156RA SG10201801156RA (en)	2013-08-23	2014-08-22	Beta-casein a2 and blood glucose levels

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SG11201600670VA SG11201600670VA (en)	2013-08-23	2014-08-22	Beta-casein a2 and blood glucose levels

Country Status (18)

Country	Link
US (2)	US10568933B2 (en)
EP (2)	EP3943100A1 (en)
JP (2)	JP6866159B2 (en)
KR (2)	KR102626825B1 (en)
CN (1)	CN105555295A (en)
AU (2)	AU2014309522B2 (en)
CA (2)	CA3235298A1 (en)
ES (1)	ES2899732T3 (en)
HK (1)	HK1225618A1 (en)
IL (2)	IL243845B (en)
MX (2)	MX2016002372A (en)
MY (1)	MY192873A (en)
NZ (1)	NZ717171A (en)
PH (1)	PH12016500213A1 (en)
RU (1)	RU2698794C2 (en)
SG (2)	SG11201600670VA (en)
WO (1)	WO2015026245A1 (en)
ZA (1)	ZA201600816B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR102626825B1 (en)	2013-08-23	2024-01-17	디 에이2 밀크 컴퍼니 리미티드	Beta-casein a2 and blood glucose levels
WO2016172479A1 (en) *	2015-04-22	2016-10-27	Cedars-Sinai Medical Center	Enterically delivered bitter oligopeptides for the treatment for type 2 diabetes
CN107708711A (en)	2015-05-22	2018-02-16	艾尔牛奶有限公司	β caseins A2 and oxidation resistance
WO2017003300A1 (en) *	2015-06-29	2017-01-05	The A2 Milk Company Limited	A2 beta-casein and viscosity of milk products
KR20180096704A (en) *	2015-12-22	2018-08-29	디 에이2 밀크 컴퍼니 리미티드	Infant formula containing human breast milk peptide
JP2017165661A (en) *	2016-03-14	2017-09-21	雪印メグミルク株式会社	Carbohydrate metabolism improver
MX2018011817A (en)	2016-03-30	2019-01-24	A2 Milk Co Ltd	Beta-caseins and cognitive function.
MY186302A (en)	2016-09-30	2021-07-07	A2 Milk Co Ltd	Beta-caseins and gut microbiota

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69536000D1 (en) *	1994-11-04	2009-10-22	A2 Corp Ltd	SELECTION PROCEDURE FOR NON-DIABETIC MILK OR DAIRY PRODUCTS AND MILK OR DAIRY PRODUCED THEREBY
DK0871366T3 (en)	1995-05-16	2005-10-10	A2 Corp Ltd	Food product and method of manufacture thereof
US7094949B2 (en) *	1995-05-16	2006-08-22	A2 Corporation Limited	Breeding and milking cows for milk free of β-casein A1
EP1196047A4 (en)	1999-06-29	2004-12-22	New Zealand Milk Inst Ltd	Prophylactic dietary supplement based on milk
AU9037401A (en)	2000-09-08	2002-03-22	New Zealand Dairy Board	Milk containing beta-casein with proline at position 67 does not aggravate neurological disorders
NZ538004A (en) *	2002-07-03	2011-01-28	A2 Corp Ltd	Method for altering fatty acid composition of milk
US20060280802A1 (en) *	2002-10-04	2006-12-14	Campbell Julie H	Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2
RU2402243C2 (en) *	2004-07-19	2010-10-27	Н.В. Нютрисиа	Preparation for aspartate application for blood glucose levels control
EP2745709A1 (en) *	2012-12-24	2014-06-25	Abbott Laboratories, Inc.	Nutritional compositions with reduced beta-casein a1 and related methods
KR102626825B1 (en)	2013-08-23	2024-01-17	디 에이2 밀크 컴퍼니 리미티드	Beta-casein a2 and blood glucose levels

2014
- 2014-08-22 KR KR1020217005230A patent/KR102626825B1/en active IP Right Grant
- 2014-08-22 CA CA3235298A patent/CA3235298A1/en active Pending
- 2014-08-22 MX MX2016002372A patent/MX2016002372A/en active IP Right Grant
- 2014-08-22 EP EP21189520.6A patent/EP3943100A1/en active Pending
- 2014-08-22 ES ES14838462T patent/ES2899732T3/en active Active
- 2014-08-22 JP JP2016536060A patent/JP6866159B2/en active Active
- 2014-08-22 SG SG11201600670VA patent/SG11201600670VA/en unknown
- 2014-08-22 US US14/913,525 patent/US10568933B2/en active Active
- 2014-08-22 CA CA2920152A patent/CA2920152A1/en active Pending
- 2014-08-22 MY MYPI2016700569A patent/MY192873A/en unknown
- 2014-08-22 SG SG10201801156RA patent/SG10201801156RA/en unknown
- 2014-08-22 RU RU2016103489A patent/RU2698794C2/en active
- 2014-08-22 EP EP14838462.1A patent/EP3035951B1/en active Active
- 2014-08-22 AU AU2014309522A patent/AU2014309522B2/en active Active
- 2014-08-22 CN CN201480046351.4A patent/CN105555295A/en active Pending
- 2014-08-22 WO PCT/NZ2014/000172 patent/WO2015026245A1/en active Application Filing
- 2014-08-22 KR KR1020167007438A patent/KR102270059B1/en active IP Right Grant
- 2014-08-22 NZ NZ717171A patent/NZ717171A/en unknown
2016
- 2016-01-28 IL IL243845A patent/IL243845B/en active IP Right Grant
- 2016-01-29 PH PH12016500213A patent/PH12016500213A1/en unknown
- 2016-02-05 ZA ZA2016/00816A patent/ZA201600816B/en unknown
- 2016-02-23 MX MX2020006720A patent/MX2020006720A/en unknown
- 2016-12-06 HK HK16113898A patent/HK1225618A1/en unknown
2018
- 2018-01-30 IL IL257228A patent/IL257228B/en active IP Right Grant
- 2018-09-20 JP JP2018175833A patent/JP7082551B2/en active Active
2019
- 2019-06-12 AU AU2019204101A patent/AU2019204101B2/en not_active Withdrawn - After Issue
2020
- 2020-01-09 US US16/738,852 patent/US20200129590A1/en not_active Abandoned

Also Published As

Publication number	Publication date
KR20210022776A (en)	2021-03-03
EP3035951A4 (en)	2017-04-19
EP3943100A1 (en)	2022-01-26
US10568933B2 (en)	2020-02-25
AU2019204101A1 (en)	2019-07-04
JP2019011342A (en)	2019-01-24
CN105555295A (en)	2016-05-04
ZA201600816B (en)	2017-11-29
EP3035951B1 (en)	2021-09-15
IL243845A0 (en)	2016-04-21
AU2019204101B2 (en)	2021-09-02
MX2020006720A (en)	2020-08-20
PH12016500213B1 (en)	2016-04-25
MX2016002372A (en)	2016-12-20
US20200129590A1 (en)	2020-04-30
JP6866159B2 (en)	2021-04-28
KR102626825B1 (en)	2024-01-17
AU2014309522A1 (en)	2016-03-10
WO2015026245A1 (en)	2015-02-26
RU2016103489A3 (en)	2018-06-18
KR102270059B1 (en)	2021-06-28
RU2698794C2 (en)	2019-08-30
HK1225618A1 (en)	2017-09-15
NZ717171A (en)	2022-05-27
IL257228B (en)	2020-02-27
SG11201600670VA (en)	2016-02-26
RU2016103489A (en)	2017-09-28
IL257228A (en)	2018-03-29
AU2014309522B2 (en)	2019-11-07
CA3235298A1 (en)	2015-02-26
IL243845B (en)	2018-02-28
EP3035951A1 (en)	2016-06-29
ES2899732T3 (en)	2022-03-14
MY192873A (en)	2022-09-13
US20160324922A1 (en)	2016-11-10
JP2016532702A (en)	2016-10-20
KR20160044580A (en)	2016-04-25
JP7082551B2 (en)	2022-06-08
PH12016500213A1 (en)	2016-04-25
CA2920152A1 (en)	2015-02-26

Publication	Publication Date	Title
IL269877B (en)	2021-05-31	Blood pump systems and methods
HK1214112A1 (en)	2016-07-22	Non-invasive blood analysis
IL257228B (en)	2020-02-27	Beta-casein a2 and blood glucose levels
GB202005994D0 (en)	2020-06-10	Patient interface and aspects thereof
IL243310B (en)	2019-01-31	Juice extractor and juice extractor body
EP2968894A4 (en)	2016-12-21	Medical connector
GB201314953D0 (en)	2013-10-02	Catheter Assembley
HK1218784A1 (en)	2017-03-10	Imaging blood cells
HK1222468A1 (en)	2017-06-30	Dual function medical benefits card
SG11201604537UA (en)	2016-07-28	Implantable biosensor
HK1223529A1 (en)	2017-08-04	Low glucose treatment for people with diabetes
HK1214861A1 (en)	2016-08-05	Blood glucose meter
EP2990010A4 (en)	2016-11-30	Artificial blood vessel
EP2965723A4 (en)	2016-12-21	Medical stent
EP2967641A4 (en)	2016-04-06	Microblister skin grafting
HK1219962A1 (en)	2017-04-21	Human anti-il-32 antibodies -32
GB201305761D0 (en)	2013-05-15	Blood Pump
GB201305758D0 (en)	2013-05-15	Blood Pump
EP2949274A4 (en)	2016-11-02	Heart treatment device
EP2992915A4 (en)	2016-11-09	Medical aid
GB201307872D0 (en)	2013-06-12	Medical use
HK1214347A1 (en)	2016-07-22	Blood glucose meter
GB201309498D0 (en)	2013-07-10	Novel diagnosis and therapy
CL2016000287A1 (en)	2016-12-16	Levels of beta-casein a2 and blood glucose
AU355656S (en)	2014-05-21	Blood glucose meter